EUVIMEDEUVIMED entdecken
Crossref

Expression Profile of LncRNAs in Childhood Acute Lymphoblastic Leukemia: A Pilot Study

Zohreh Mousavi, Saeid Ghorbian, Azim Rezamand, Leyla Roshangar, Behboud Jafari

Pharmaceutical Sciences · 29.10.2020 · 27 (3) · 385-392

DOI: 10.34172/ps.2020.84 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Sciences, online erschienen am 29.10.2020. Verfasst von Zohreh Mousavi und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Childhood acute lymphoblastic leukemia (ALL) explains 26% of pediatricmalignancies and is one of the leading causes of disease-related deaths in children. A novelmolecular class of non-coding genes, long non-coding RNAs (lncRNAs) having over 200nucleotides, have been defined as regulators of different cellular processes including pluripotency,oncogenesis, and transcription. It has been demonstrated that lncRNA transcription profilescan distinguish pre B-cell subtype of ALL accurately and act as early diagnostic and prognosticbiomarkers. Hence, the aim of this pilot study was the prior evaluation of expression profileof several lncRNA candidates including RP11-68I18.10, RP11-624C23.1, RP11-446E9, RP11-137H2.4, and RP11-203E8 in patients with ALL.

Methods

In this study, 80 blood samples were obtained from patients, definitely diagnosed bypathologists with ALL, and from healthy subjects. Total RNA was extracted from blood samples,and cDNA was synthesized. Real-time PCR was applied to determine the expression of lncRNAs.A P-value of 0.010 was considered statistically significant.

Results

Our findings revealed that the expression levels of lncRNAs RP11-624C23.1, RP11-446E9, RP11-137H2.4, RP11-68I18.10, and RP11-203E8 were significantly decreased in ALLsamples compared to those of healthy samples (P

Zitieren

APA

Mousavi, Z., Ghorbian, S., Rezamand, A., Roshangar, L., & Jafari, B. (2020). Expression Profile of LncRNAs in Childhood Acute Lymphoblastic Leukemia: A Pilot Study. Pharmaceutical Sciences, 27(3), 385-392. https://doi.org/10.34172/ps.2020.84

Vancouver

Mousavi Z, Ghorbian S, Rezamand A, Roshangar L, Jafari B. Expression Profile of LncRNAs in Childhood Acute Lymphoblastic Leukemia: A Pilot Study. Pharmaceutical Sciences. 2020;27(3):385-392. doi:10.34172/ps.2020.84

BibTeX
@article{Mousavi2020,
  author = {Mousavi, Zohreh and Ghorbian, Saeid and Rezamand, Azim and Roshangar, Leyla and Jafari, Behboud},
  title = {Expression Profile of LncRNAs in Childhood Acute Lymphoblastic Leukemia: A Pilot Study},
  journal = {Pharmaceutical Sciences},
  year = {2020},
  volume = {27},
  number = {3},
  pages = {385--392},
  doi = {10.34172/ps.2020.84}
}
Kostenlos starten →